glp-1 dual agonist GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Schematic illustration of monoagonists, dual
Description
6 Inhibiting the DPP-4 enzyme enhances the action of GLP-1 by prolonging the half-life and increasing circulating GLP-1
Perfect for that post-semaglutide sluggishness
doi: 10.1152/physrev.00034.2006 37 MarsoSPDanielsGHBrown-FrandsenKKristensenPMannJFNauckMAet al
Guidance for Industry: drug interaction studiesstudy design, data analysis, implications for dosing, and labeling recommendations
For patients, the implications are immediate and tangible
L.J.D., H.M.P., E.F., S.L.B., S.D.G., B.M., and D.C.P
